Literature DB >> 11064962

Placebo effects in autism: lessons from secretin.

A D Sandler1, J W Bodfish.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11064962     DOI： 10.1097/00004703-200010000-00005

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN： 0196-206X            Impact factor:   2.225


× No keyword cloud information.
  9 in total

Review 1.  Intervention in the context of development: pathways toward new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Zachary Warren
Journal:  Neuropsychopharmacology       Date:  2014-09-03       Impact factor: 7.853

2.  Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder?

Authors:  Adrian D Sandler; Corrine E Glesne; James W Bodfish
Journal:  J Dev Behav Pediatr       Date:  2010-06       Impact factor: 2.225

Review 3.  Secretin as a treatment for autism: a review of the evidence.

Authors:  Barbara E Esch; James E Carr
Journal:  J Autism Dev Disord       Date:  2004-10

4.  Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism.

Authors:  Tracy Carey; Karen Ratliff-Schaub; Jeanne Funk; Chris Weinle; Melissa Myers; Jennifer Jenks
Journal:  J Autism Dev Disord       Date:  2002-06

5.  Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin.

Authors:  S E Levy; M C Souders; J Wray; A F Jawad; P R Gallagher; J Coplan; J K Belchic; M Gerdes; R Mitchell; A E Mulberg
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

Review 6.  Pharmacotherapy for the core symptoms in autistic disorder: current status of the research.

Authors:  Cristan Farmer; Audrey Thurm; Paul Grant
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

7.  'Emotiplay': a serious game for learning about emotions in children with autism: results of a cross-cultural evaluation.

Authors:  S Fridenson-Hayo; S Berggren; A Lassalle; S Tal; D Pigat; N Meir-Goren; H O'Reilly; S Ben-Zur; S Bölte; S Baron-Cohen; O Golan
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-03-08       Impact factor: 4.785

8.  Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis.

Authors:  Aurore Curie; Kathy Yang; Irving Kirsch; Randy L Gollub; Vincent des Portes; Ted J Kaptchuk; Karin B Jensen
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

9.  Certainty of genuine treatment increases drug responses among intellectually disabled patients.

Authors:  Karin B Jensen; Irving Kirsch; Moa Pontén; Annelie Rosén; Kathy Yang; Randy L Gollub; Vincent des Portes; Ted J Kaptchuk; Aurore Curie
Journal:  Neurology       Date:  2017-04-19       Impact factor: 9.910
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.